Acute Promyelocytic Leukemia
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML), characterized by a balanced translocation between chromosome...
#targeted therapy
12 articles
Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a indolent B-cell malignancy characterized by the progressive accumulation of mature-appearing but functionally ...
Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by the Philadelphia chromosome—a reciprocal translocation be...
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common histological subtype of lung malignancy, accounting for approximately 85% of all lung cancer cas...
Cancer Patients and Food Restrictions: What’s Actually Off-Limits, According to Oncologists
“Cancer patients must avoid eggs—they’ll cause swelling!” “Honey feeds tumor cells!” These kinds of dietary warnings circulate relentlessly on social ...
Lung Cancer
Lung cancer, a malignant neoplasm originating in bronchial epithelial cells or pulmonary parenchyma, remains the leading cause of cancer-related morta...
Renal Cell Carcinoma
Renal cell carcinoma (RCC), the most common type of kidney cancer in adults, originates in the proximal convoluted tubule epithelial cells. Accounting...
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung malignancies and encompasses several histological subtypes—including ade...
HER2-Positive Breast Cancer
HER2-positive breast cancer is an aggressive subtype characterized by overexpression or amplification of the human epidermal growth factor receptor 2 ...
EGFR-Mutated NSCLC
EGFR-mutated non-small cell lung cancer (NSCLC) is a molecularly defined subtype of lung adenocarcinoma characterized by activating mutations in the e...
ALK-Fusion NSCLC
ALK fusion-positive non-small cell lung cancer (NSCLC) is a molecularly defined subtype of lung adenocarcinoma characterized by chromosomal rearrangem...
ROS1-Fusion NSCLC
ROS1 fusion-positive non-small cell lung cancer (NSCLC) is a molecularly defined subtype occurring in approximately 1–2% of NSCLC cases, characterized...